CMR Surgical Secures $200m for US Expansion
Deal News | Apr 02, 2025 | UK Tech Funding
CMR Surgical, a Cambridge-based medical robotics firm, has successfully secured a $200 million funding round, backed by notable investors including SoftBank, Tencent, and Trinity Capital. The funding aims to support the commercialisation and launch of CMR's Versius surgical robotic system in the US, a market valued at over $567 billion. Versius, which has been used in over 30,000 surgical cases across more than 30 countries, is designed for procedures such as colorectal, gynaecology, thoracic, and urology surgeries. As CEO Massimiliano Colella notes, CMR is at a pivotal stage, focusing on market expansion in the US and deepening its market presence worldwide. The funding highlights confidence in CMR’s vision and the transformative potential of surgical robotics. UK Science Minister, Lord Vallance, endorsed the investment as a testament to the UK's dynamic life sciences sector. This round follows a prior $133 million secured in September 2023, emphasising ongoing support for CMR’s innovations.
Sectors
- Medical Robotics
- Life Sciences
- Venture Capital
Geography
- United Kingdom – Home base for CMR Surgical and a hub for life sciences innovation.
- United States – The primary target market for CMR Surgical's expansion efforts.
- China – A key market due to the involvement of investor Tencent, reflecting broader international stakeholder interest.
Industry
- Medical Robotics – The core industry focus of CMR Surgical, involving the development of robotic systems for medical procedures.
- Life Sciences – Related to the broader spectrum of healthcare innovations and technologies to which CMR Surgical contributes.
- Venture Capital – Involves the investment provided by firms like Trinity Capital to advance the growth and commercialisation of technologies like those from CMR Surgical.
Financials
- $200 million – The total amount raised by CMR Surgical in the latest funding round.
- $133 million – The amount previously raised by CMR Surgical in September 2023.
- $567 billion – The estimated medtech market size in the US targeted by CMR Surgical.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| CMR Surgical | Target | Company | A medical robotics firm based in Cambridge, known for its Versius surgical system. |
| Trinity Capital | Investor | Company | A new investor in CMR Surgical's latest funding round. |
| SoftBank | Investor | Company | An existing backer of CMR Surgical, involved in the latest funding round. |
| Tencent | Investor | Company | An existing backer of CMR Surgical, involved in the latest funding round. |
| Massimiliano Colella | CEO | Person | CEO of CMR Surgical, overseeing the company's strategic initiatives. |
| Rob Lake | Senior Managing Director of Life Sciences | Person | Represents Trinity Capital in the investment, supporting CMR Surgical’s vision. |
| Lord Vallance | UK Science Minister | Government | Championing the UK Cambridge corridor and supporter of CMR Surgical’s innovation. |